Book Value per Share: Athira Pharma, Inc. (ATHA)

Athira Pharma, Inc. (ATHA) - corporate logo

Athira Pharma, Inc. (ATHA) is implementing AI robotics for the design of Alzheimer's compounds and reducing its carbon footprint through closed-loop water systems. The book value per common share on GURU.Markets reflects these processes, where 6.75 represents the latest metric reading. Management is currently revising its R&D strategy and seeking new neurological programs following unsuccessful tests of its lead drug candidate.

Athira Pharma Inc (ATHA) Equity per Share: for the period 07/04/2022 - 01/12/2026

athira.com - analytical breakdowns and key metrics (ATHA)

- price and consensus price forecast:
Stock Price Athira|ATHA - Fair Value Consensus
- market capitalization data:
Market Capitalization Athira Pharma, Inc.|ATHA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Athira Pharma|ATHA - Accounting Capitalization|Market Capitalization to Book Value Ratio athira.com|ATHA - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Athira Pharma, Inc.|ATHA - Long-Term Debt to Capital|Short-Term Debt to Equity Athira Pharma|ATHA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Athira Pharma, Inc.|ATHA - Long-Term Debt|Company Short-Term Debts Athira Pharma
Fundamental company valuation:Athira, ATHA
Manufactured products of Athira Pharma

Investments in the robotic molecule screening of Athira Pharma, Inc. (ATHA) require an analysis of net assets, which determine the intrinsic value of the business minus liabilities. The current value of 6.75, reflected through the book value per share, demonstrates the actual size of the equity on paper, allowing the investor to assess the company's margin of safety relative to market volatility and development risks.

Competitors of Athira Pharma, Inc. (ATHA)

Book Value per Share Biogen Corp (BIIB)|NBIX - Accounting Value of a Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share anavex.com (AVXL)|Accounting Value per Share CeriBell|Book Price of a Share Prothena Corporation (PRTA)|Book Value per Share Alector|Accounting Value of a Share Annexon Biosciences Inc. ANNX|Book Value per Share OMER (Omeros Corp.)|NGNE: Net Assets per Share|Net Assets per Single Share AC Immune SA ACIU|Voyager Therapeutics Inc (VYGR) - Accounting Value of a Share|NMRA (Neumora Therapeutics Inc) - Book Value per Share|Book Value per Share Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Accounting Value per Share|Accounting Value of a Share ACOG (alphacognition.com)|Cognition Therapeutics (CGTX) - Net Assets per Single Share|Share Book Value Inhibikase Therapeutics Inc IKT|Book Value per Share Cassava (SAVA)|ASRT - Accounting Value of a Share|COYA: Book Value per Share|VTGN (Vistagen) - Book Value per Share|OVID - Net Assets per Single Share|Accounting Value of a Share ABOS|Net Assets per Single Share CRVO (CervoMed Inc)|Accounting Value per Share alteritytherapeutics.com (ATHE)|Book Value per Share CLNN (Clene)|PEPG - Book Value per Share|Accounting Value per Share Jupiter Neurosciences Inc (JUNS)|RLMD - Accounting Value of a Share|Annovis Bio Corp - Book Value per Share|GRCE (Grace Therapeutics) - Net Assets per Share|Net Assets per Single Share Firefly Neuroscience, Inc (AIFF)|Equity per Share ANEW Medical, Inc.|Book Value per Share NRSN (NeuroSense Therapeutics)|Accounting Value per Share Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Value per Share MTVA|Net Assets per Share NeurAxis Inc NRXS|Helius Medical Technologies Inc. - Book Value per Share|Passage Bio, Inc. (PASG) - Book Value per Share|NEUP - Accounting Value per Share|Minerva Neurosciences Inc (NERV) - Book Price of a Share|ADXN - Book Value per Share|Accounting Value of a Share Alzamend|Book Value per Share CYCN|Book Value per Share PTIX (protagenic.com)|KTTA - Net Assets per Single Share|Equity per Share Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Net Asset Value per Share|CARA: Accounting Value per Share|CHRO (chromocell.com) - Book Value per Share|ELYM - Net Assets per Single Share|Accounting Value of a Share ITCI|Longboard Pharma - Net Assets per Single Share|Net Asset Value per Share Marinus Pharma (MRNS)|Book Value per Share NKGN (NKGen Biotech, Inc.)|NRBO - Book Value per Share|Accounting Value per Share Sage Therapeutics SAGE|SNPX - Book Price of a Share|Book Value per Share Trevena, Inc TRVN|Vigil Neuroscience, Inc. (VIGL) - Accounting Value of a Share|WENA: Book Value per Share|Net Assets per Share CERE